Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Narcotrend-guided propofol sedation for paediatric gastrointestinal endoscopy
NL-OMON28327Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Jul 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of propofol and remifentanil (2 arms), sponsored by Erasmus MC. Primary endpoint: Speed of recovery from procedural sedation. Planned start Jul 2013; status: not yet recruiting.
02
Drugs
propofolremifentanil
Beyond the preview
Go deeper on NL-OMON28327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28327.